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It is now well recognized that mutations in the hepatitis B virus (HBV) genome occur during the natural course of chronic
viral infection. Regions of the viral genome that are frequently affected by such mutations, rearrangements, and/or deletions
generally involve the precore promoter, precore, and core as well as the preS gene regions. However, little is known
regarding the biologic consequences of these mutations on the functional properties of the variant viral strains with respect
to effects on viral replication. In this study, we investigated the functional significance of precore promoter and precore
gene mutations that reduce or abolish the synthesis of hepatitis B e antigen (HBeAg). We found that precore promoter
mutations diminished the expression of HBeAg but did not affect the synthesis of pregenomic RNA. However, these precore
mutations were associated with a modest increase in HBV replication. In contrast, a naturally occurring mutant that carries
a termination codon in position 28 of the precore open reading frame demonstrated increased encapsidation of pregenomic
mRNA into nucleocapsid particles. Consequently, this variant viral strain demonstrated a substantial increase in the level
of viral replication compared to ‘‘wild-type’’ HBV and other precore promoter mutant viral strains. These studies suggest
that substitutions in the precore promoter and precore gene not only alter the synthesis of HBeAg but also affect the level
of viral replication. q 1997 Academic Press
INTRODUCTION degree of viremia. Indeed, HBV DNA levels have been
found to decline in serum following the development of
The hepatitis B virus (HBV) is the prototype member an immune response to HBeAg (anti-HBe) (Carman and
of the hepadnavirus family (McLachlan, 1991). HBV is a Thomas, 1993).
major cause of acute and chronic hepatitis and persistent
It is now recognized that chronic HBV infection is asso-
infection is often associated with the development of liver
ciated with the emergence of mutations throughout the
cirrhosis and hepatocellular carcinoma (Lau and Wright,
viral genome that result in the generation of diverse viral
1993; Wands and Blum, 1991). The viral genome is made
populations or quasispecies. In this regard, viral ge-
of a partially double-stranded 3.2-kb DNA molecule ar-
nomes defective in HBeAg synthesis (HBeAg0 strains)ranged in a relaxed circular conformation. HBV encodes
are frequently found during persistent viral infection. Thefour partially overlapping open reading frames (ORF) des-
biological properties of these naturally occurring HBVignated as precore/core, polymerase, preS/s, and X. The
mutants is controversial. They have been linked to fulmi-precore gene product is a 25-kDa protein that contains
nant hepatitis and associated with high levels of viralat the amino terminus a signal peptide sequence that
replication (Carman et al., 1991; Liang et al., 1991; Omatadirects it to the secretory pathway within the cell (Ou et
et al., 1991). Moreover, such viral strains have been foundal., 1986). An intermediate 22-kDa protein is produced
in individuals with chronic hepatitis B (Brunetto et al.,by cleavage of the 19-aa signal peptide and this species
1989; Carman et al., 1989; Naoumov et al., 1992; Okamotois either translocated into the lumen of the endoplasmic
et al., 1990; Tong et al., 1990). At the molecular level, thereticulum or released back into the cytoplasm (Garcia et
most prevalent mutation described is a transition fromal., 1988). The translocated p22 protein is further pro-
TGG to TAG that introduces an amber termination signalcessed at the carboxy terminus to generate a 17-kDa
at codon 28 in the precore ORF. Some studies have re-soluble monomeric product that is secreted from the cell
ported that these mutations result in increased levels ofas the HBeAg (Standring, 1991). HBeAg is found in serum
viral replication (Lamberts et al., 1993; Scaglioni et al.,during active infection and generally correlates with the
1997); however, no effects on HBV DNA synthesis have
been reported in other studies (Yuan et al., 1995; Hase-
1 These authors contributed equally to this work. gawa et al., 1994; Tong et al., 1992).
2 To whom correspondence and reprint requests should be ad- Point mutations in the precore promoter (Yu and Mertz,dressed at Molecular Hepatology Laboratory, Massachusetts General
1996) have been found as an isolated event or in associa-Hospital Cancer Center, 149 13th Street, 7th Floor, Charlestown, MA
02129. Fax: (617) 726-5609. tion with the termination codon at position 28 in the pre-
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core ORF (Okamoto et al., 1994; Sato et al., 1995; Laskus fragment from pC*28 into payw1.2. This plasmid has the
stop codon at position 28 in the precore ORF and the otheret al., 1995; Baumert et al., 1996). The most frequent
mutations involve an A-to-T and a G-to-A exchange at aforementioned precore/core ORF mutations but contains
a wild-type precore and core promoter sequence. The pay-nucleotides (nts) 1760 and 1762 in the precore promoter.
A liver-enriched transcription factor has been found to wOM construct was generated by introducing an AatII–
FspI fragment derived from pC*28 into payw1.2. Therefore,bind to this region of the precore promoter (Guo et al.,
1993; Zhang and McLachlan, 1994). A recent study dem- this construct has 12 nucleotide substitutions upstream of
and including the precore promoter mutations with the se-onstrated that a HBV genome carrying the mutations at
nts 1760 and 1762 displayed reduced levels of HBeAg quence ATGAT (nts 1759–1763) but contains the wild-type
HBV precore/core genes. The plasmid paywXB was ob-synthesis in vitro and was associated with enhanced
viral replication (Buckwold et al., 1996). It has been re- tained by introducing an XbaI–BspEI (nts 1988–2327) frag-
ment obtained from pC*28 into the payw1.2 construct. Thisported that another double mutation at nts 1764 and 1766
may affect pregenomic RNA encapsidation, leading to plasmid contains 12 mutations in the core gene.
Specific point mutations were created in the wild-typeincreased levels of viral replication (Baumert et al., 1996).
However, it should be noted that different HBV genotypes HBV of D genotype by site-directed mutagenesis (pAlter
system, Promega Corp.). In this regard, the paywOMPMhave been studied and some of the differences found in
viral replication may be the result of mutations in other carries the double mutation of A to T and G to A at nts 1760
and 1762, respectively. The pawyFHPM carries a doubleregions of the viral genome. In the present report, we
investigated the functional consequences of introducing mutation of C to T and of T to A at nts 1764 and 1766 in the
precore promoter sequence. These mutations have beenmutations in the precore promoter/precore gene of a
‘‘wild-type’’ HBV genome (Galibert et al., 1979) character- proposed to be important in the generation of a fulminant
hepatitis B viral strain (Baumert et al., 1996). Theized as the D genotype (Norder et al., 1994). The biologic
effects of these mutations were assessed with respect to payw*28PM carries the nonsense TGG to TAG mutation
that introduces a stop codon in the precore ORF at codonviral replication, antigen secretion, viral mRNA synthesis,
and pregenomic RNA encapsidation. 28. In addition, the plasmid pCMVHBV*28PM was gener-
ated to carry the nonsense TGG to TAG mutation into the
pCMVHBV vector that expresses the pregenomic RNA un-MATERIALS AND METHODS
der the control of the CMV IE promoter (Fallows and Goff,
Plasmid constructs
1995). This construct was designed as pCMVHBV*28PM.
The pZeroDB plasmid was prepared by cloning the DraI–The plasmid vectors used in this study are depicted
in Fig. 1. All constructs were derived from the previously BglII (nts 1720–1982) HBV insert into the EcoRV–BamHI
sites of the pZero-2.1 polylinker (Invitrogen, San Diego, CA).described payw1.2 plasmid (Scaglioni et al., 1997). This
construct consists of a more-than-one HBV-genome- The correct design of the plasmids was assessed by re-
striction enzyme mapping and by direct DNA sequencing.length sequence of genotype D (Galibert et al., 1979;
Norder et al., 1994) from nts 1411 to 2327 (where nt 1 is The restriction enzymes were purchased from New En-
gland Biolabs (Beverly, MA). Sequence reactions were car-by convention located at the GAATTC of the unique EcoRI
site) and has been cloned into the AatII and SmaI sites ried out with the Sequenase Version 2.0 enzyme (U.S. Bio-
chemicals, Cleveland, OH). Plasmids were grown in JM109of the pGEM7 Zf(/) vector (Promega Corp., Madison,
WI). The HBV RNA transcripts are expressed under the Escherichia coli cells and purified by a commercially avail-
able kit using the manufacturer’s instructions (Wizard maxi-control of endogenous viral regulatory sequences.
The construct payw*28AB has a 0.9-kb AatII–BspEI frag- prep kit; Promega Corp.).
ment insert from the pC*28 plasmid. The pC*28 construct
contains a dimer of a HBV DNA derived from serum of an Tissue culture
individual with a naturally occurring HBeAg0 mutant HBV
infection (Tong et al., 1992). This mutant carries the TGG The HepG2 and HuH-7 cell lines were transiently
transfected by means of the calcium phosphate methodto TAG nonsense mutation which introduces a termination
codon in the precore ORF at codon 28. In addition, this (CaPO4 transfection Kit, 5*-3*, Inc., Boulder, CO) with 10
mg of plasmid expressing wild-type or mutant HBV DNA.DNA fragment also carries 12 other nucleotide substitutions
upstream of and including the precore promoter and other The transfection procedure and maintenance of these
cell lines in tissue culture have been previously de-21 mutations in the precore/core ORF. In particular, this
HBV carries the mutated sequence ATGAT (nts 1759–1763) scribed (Scaglioni et al., 1994). Transfection efficiency
was monitored by adding 1 mg of pCMV luciferase con-(wild-type D genotype is AAGGT) that has been described
in naturally occurring HBV mutants either alone or in combi- struct, and approximately 1/100 of the cell lysate was
subjected to a luciferase assay (Ausubel et al., 1989).nation with the stop codon mutation in the precore ORF at
codon 28 (Okamoto et al., 1994). The plasmid paywFB was Experiments were discharged if luciferase activity varied
more than 20% between the cell lysates derived fromgenerated by exchanging the FspI–BspEI (nts 1798–2327)
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FIG. 1. Genetic organization of the plasmids used in the study. The payw1.2 construct contains a more-than-one-genome-length sequence that
expresses HBV RNAs under the control of the endogenous promoters. The core promoter region is depicted as a shorter box whereas the precore
and core ORFs are represented by taller boxes. The payw*28AB, paywFB, paywOM, and paywXB constructs were generated by cassette exchange
(as depicted by the shaded boxes) of a naturally occurring HBV mutant carrying mutations in the precore promoter (as represented by black dots)
and the amber termination signal at codon position 28 in the precore ORF (asterisk). The plasmids payw*28PM, paywOMPM, and paywFHPM were
prepared by site-directed mutagenesis as described under Materials and Methods. The pCMVHBV construct expresses the pregenomic RNA under
the control of CMV IE promoter. The pCMVHBV*28 carries a single nucleotide substitution that introduces the amber stop codon mutation in position
28 of the precore gene. The arrows indicate the positions of introduced mutations in the precore promoter.
transfected cells. The quantity of sample to be analyzed Measurement of viral antigens
was adjusted according to the level of luciferase activity.
The presence of HBV antigens was measured in theMoreover, the HBsAg concentration was measured in
supernatant of cells 5 days after transient transfectionthe culture supernatant and was used as a second inde-
with wild-type and mutant viral genomes. The HBeAgpendent assay to determine transfection efficiency. Every
assay was performed using a specific radioimmunoas-transfection experiment was repeated at least three
say (RIA) kit (EBK 125I RIA KIT, Incstar Corp., Stillwater,times with two different plasmid preparations to ensure
MN). It should be emphasized that the monoclonal anti-reproducibility of the results. Following transfection of
body used in this kit is specific for HBeAg and does notcells, viral RNA and DNA was extracted at 2 and 5 days,
cross-react with the HBV core protein. Measurement ofrespectively.
HBsAg in the cell culture supernatants was performed
Analysis of viral replication using a radioimmunometric assay as previously de-
scribed (Melegari et al., 1994). All measurements wereLevels of DNA replication were determined by South-
performed in the linear range of the assay so as to obtainern blot analysis. HBV DNA was extracted from purified
quantitative results.core particles following transient transfection as de-
scribed (Pugh et al., 1988). Prehybridization, hybridiza-
tion, and washing of the Southern blots were performed Western blot analysis
as previously described (Melegari et al., 1994). The
Western blot analysis of lysates derived from tran-bands on the gels were analyzed with a PhosphoImager
siently transfected cells was performed as describedsystem and the results obtained from at least three inde-
(Scaglioni et al., 1997). HBV core protein was revealedpendent experiments were averaged (Molecular Imaging
by polyclonal rabbit anti-core antiserum (Dako Co., Car-System, Model GS-363, Bio-Rad Laboratories, Inc., Her-
cules, CA). pinteria, CA).
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Extraction and analysis of viral RNA
Total RNA was extracted 2 days after transient trans-
fection as previously described (Scaglioni et al., 1994).
Core particles derived from the cytoplasm of transfected
cells were immunoprecipitated by a rabbit polyclonal
anti-core antibody (Dako Corp.), followed by protein A –
Sepharose precipitation. A digestion with 16 U of RNase-
free RQ1 DNase was carried out on the pelleted beads
followed by an additional wash in the presence of 50
mM EDTA. After these procedures the encapsidated viral
RNA was extracted as described (Scaglioni et al., 1994).
A RNase protection assay was performed on encapsi-
dated viral RNA using a commercially available kit (RPA
II-Ribonuclease protection kit, Ambion Inc., Austin, TX).
The viral-specific RNA probe was obtained by incubation
of the XhoI linearized pZeroDB with SP6 polymerase (Pro-
mega Corp.) in the presence of [a-32P]UTP (100 mCi at
3000 Ci/mmol, New England Nuclear, Boston, MA) as
described (Ausubel et al., 1989). The resulting RNA probe
contains a 262-nt specific antisense HBV sequence and
a 57-nt plasmid sequence that will not be protected by
digestion after hybridization with the HBV RNAs. This
probe is predicted to protect from RNase digestion two
segments of the pregenomic RNA: a 166- and a 200-nt
species located at the 3* and 5* ends, respectively, of
the terminally redundant region of the pregenomic RNA
FIG. 2. The presence of a termination signal at position 28 in the(Nassal et al., 1990; McLachlan, 1991). Hybridizations
precore ORF leads to a high-replication phenotype. (Top) Southern
and RNase digestions were performed as previously de- blot analysis of HBV DNA extracted from intracellular core particles,
scribed using encapsidated pregenomic RNA derived following transient transfection into HuH-7 cells. The arrows on the left
indicate the relaxed circular (RC), double-stranded linear (DL), andfrom a 10-cm dish of transiently transfected HuH-7 cells
single-stranded (SS) HBV DNA species. Molecular weight standards(Scaglioni et al., 1994). The RNA fragments protected by
are indicated by the arrows on the right. (Bottom) RadioimmunoassayRNase digestion were separated on a 6% polyacrylamide
results of HBsAg and HBeAg secreted into the culture supernatants
denaturing gel. Northern blot analysis of total cellular following transfection of HuH-7 cells by the constructs depicted above.
RNA was performed as previously described (Scaglioni Note that there was no change in HBsAg levels when comparing wild-
type payw1.2 to mutant HBV genomes whereas HBeAg was absent inet al., 1997). The bands on the gels were analyzed by
the supernatant of cells transfected with payw*28AB and paywFB andphosphoimaging (Molecular Imaging System Model GS-
greatly reduced in the supernatant of cells transfected with a plasmid363, Bio-Rad Laboratories, Inc.).
that contained precore promoter mutations as represented by paywOM.
The paywFB contains mutations only in the core gene. neg represents
mock DNA transfected cells.RESULTS
HBV genomes carrying naturally occurring mutations
containing the mutations were exchanged into the paren-in the precore promoter and precore gene display an
tal payw1.2 wild-type construct. The paywFB constructenhanced replication phenotype
also exhibited a similar high-replication phenotype as
compared to the payw*28AB genome (Fig. 2), while theIncreased levels of HBV replication were observed in
HCC cells transiently transfected with a more-than-one- paywOM construct exhibited an average twofold increase
in the level of replication when compared to the wild-typeHBV-genome-length vector containing naturally occurring
mutations in the precore promoter and the precore gene. payw1.2 HBV. The paywXB construct contains mutations
only in the central portion of the core gene. TransientFigure 2 shows a representative experiment. Southern blot
analysis of purified HBV core particles demonstrated that transfection experiments demonstrated that the paywXB
displays very similar replication levels to wild-typetransfection of payw*28AB in HuH-7 cells resulted in a
fivefold increase (average of three experiments) in HBV payw1.2 (Fig. 2). Transfection experiments were per-
formed in both HepG2 and HuH-7 HCC cell lines to ex-DNA replicative forms as compared to the wild-type
payw1.2 construct (Fig. 2). To characterize the specific clude the possibility that the differences in viral replication
were related to cell type and similar results were obtainedmutation(s) responsible for this high-replication pheno-
type, smaller fragments of the AatII–BspEI DNA insert with both cell lines (data not shown).
AID VY 8594 / 6a3b$$$$22 06-06-97 13:42:13 vira AP: Virology
378 SCAGLIONI, MELEGARI, AND WANDS
mutations in the wild-type payw1.2 HBV genome closely
resembled the findings described above with the natu-
rally occurring viral mutants.
We also compared the pattern of HBV replication of
paywFHPM to wild-type payw1.2. This plasmid was engi-
neered to contain a double-nucleotide substitution in the
precore promoter region that has been recently de-
scribed as important in conferring a high-replication phe-
notype in a ‘‘fulminant’’ hepatitis B viral strain (Baumert
et al., 1996). This construct directed the synthesis of a
twofold (average of three experiments) increase of viral
replicative forms as compared to wild-type payw1.2.
However, the levels are much lower than those found
with payw*28PM (Fig. 3). To ascertain that the introduc-
tion of the nonsense mutation resulting in a stop codon
at position 28 of the precore gene did not affect the
encapsidation efficiency and DNA priming of the prege-
nomic RNA, this same mutation was introduced into the
pCMVHBV construct. This plasmid does not express pre-
core mRNA and as a consequence does not synthesize
HBeAg. The pCMVHBV and pCMVHBV*28 exhibited simi-
lar levels of HBV replication following transfection into
HuH-7 cells (Fig. 3).
Effect of the mutations in the precore promoter and
precore ORF on viral antigen production
FIG. 3. The termination signal introduced at codon 28 in the precore
ORF is sufficient to produce a high-replication phenotype. (Top) South- We determined if point mutations introduced either
ern blot analysis of HBV DNA extracted from intracellular core particles into the precore promoter region or into the precore gene
produced following transient transfection of HuH-7 cells with plasmids affected the level of viral antigen synthesis. Figure 4
expressing ‘‘wild-type’’ payw1.2 and HBV genomes modified by site-
shows the results obtained in five independent experi-directed mutagenesis as described under Materials and Methods. The
ments. We have previously found that overexpression ofarrows indicate the relaxed circular (RC), double-stranded linear (DL),
and single-stranded (SS) HBV DNA species. Molecular weight stan- the precore protein did not alter HBsAg secretion (Scagli-
dards are indicated on the left of the figure. (Bottom) Radioimmunoas- oni et al., 1997). Thus, as expected HBsAg secretion was
say results of HBsAg and HBeAg levels secreted into the culture super- not affected by any of the mutations as assessed in HCC
natant of cells transfected with constructs shown above. Note that
cell lines (Figs. 2 and 3). In addition, HBeAg was unde-HBeAg was absent in the supernatant of cells transfected with
tectable in cell culture supernatant derived from cellspayw*28, pCMVHBV, and pCMVHBV*28PM. HBeAg was greatly re-
duced in the supernatant of cells transfected with plasmids that con- transfected with payw*28PM. It was of interest that the
tained precore promoter mutations as represented by paywOMPM and levels of HBeAg secreted by the paywOMPM and
paywFHPM. neg. represents cell culture supernatant derived from paywFHPM mutants were found to be reduced threefold
mock DNA transfected cells.
in cell culture supernatant derived from transfected
HepG2 cells and reduced fourfold following transfection
of HuH-7 cells as compared to the levels observed withA stop codon in the precore ORF generates a high-
wild-type payw1.2 (Fig. 4). HBeAg was undetectable inreplication viral phenotype
the culture supernatant of HuH-7 cells transfected with
It was necessary to confirm that the above-described
pCMVHBV (Figs. 3 and 4). Finally, we found that the viral
mutations were directly responsible for the high-replica-
strains carrying the precore promoter and precore muta-
tion phenotype. Therefore, we introduced defined nucleo-
tions expressed similar levels of intracellular p21 core
tide substitutions by site-directed mutagenesis. We
protein (data not shown).
found that payw*28PM exhibited a 5-fold increase (aver-
age of three experiments) in the level of viral replication Precore promoter and precore ORF mutations result
compared to the wild-type payw1.2 (Fig. 3). In addition, in increased levels of encapsidated pregenomic RNA
the plasmid aywFB showed a similar replication capacity
as represented by a 3.5-fold increase in viral replication We determined if precore promoter and precore ORF
mutations affect viral gene expression. Northern blot analy-illustrated in Fig. 3. In contrast, paywOMPM displayed
only a 2-fold increase in viral replication. Therefore, the sis performed on total cellular RNA revealed no differences
in viral gene expression between wild-type payw1.2 andphenotype exhibited by these artificially created point
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a fivefold increase in HBV DNA synthesis was associated
with a mutant viral strain that contains a precore stop
codon mutation at position 28 whereas a twofold in-
crease in HBV DNA replication was found to be associ-
ated with specific mutations in the precore promoter re-
gion. To confirm that either one of these naturally oc-
curring mutations was responsible for a high-replication
phenotype, we engineered the same mutations by site-
directed mutagenesis into the wild-type HBV as well.
First, the biologic consequences of these mutations
on expression of HBV antigens were explored. It was
found that the precore promoter mutation reduced
HBeAg synthesis to about 30% in HepG2 and 20% in
HuH-7 cells as compared to levels produced by wild-
type HBV. There was no effect of these mutations on
HBsAg secretion or on the intracellular levels of HBV
core protein. As expected, the precore stop codon muta-
tion at position 28 abolished HBeAg synthesis but did
not affect the synthesis of pregenomic RNA. These ob-
servations demonstrate that the precore promoter and
precore gene mutations do not alter the expression of
other HBV genes. Our results are in general agreement
FIG. 4. Radioimmunoassay results of HBeAg levels secreted into with recent findings indicating that precore promoter mu-
the medium following transient transfection with wild-type and various tations will result in decreased levels of precore mRNA
mutant HBV constructs in HuH-7 and HepG2 cells. The mean levels
and results in enhanced HBV replication (Buckwold etderived from five independent experiments are presented. Note that
HBeAg was absent in the supernatant of cells transfected with the
payw*28AB, payw*28PM, and pCMVHBV and substantially reduced in
cells transfected with plasmids that contained precore promoter muta-
tions as represented by paywOMPM and paywFHPM.
mutant viral genomes that could account for the observed
differences in the HBV DNA synthesis (Fig. 5A). We then
asked whether the differences in replication phenotype of
HBV mutants are due to the levels of core particles con-
taining encapsidated pregenomic RNA. The RNase protec-
tion assay revealed that the levels of encapsidated prege-
nomic RNA were fivefold higher in cells transfected with
payw*28PM as compared to wild-type payw1.2. In contrast,
the levels of encapsidated pregenomic RNA in core parti-
cles were increased twofold in cells transfected with the
paywOMPM construct containing the precore promoter mu-
tations (Fig. 5B).
DISCUSSION
In this report, we evaluated the biological properties
FIG. 5. Effect of mutations in the precore promoter and precore geneof HBV variants with mutations in the precore promoter
on the synthesis of HBV RNA derived from total cellular or encapsidatedand/or in the precore ORF since such mutations are com-
RNA derived from HuH7 cells. (A) Northern blot analysis of total cellular
monly observed during chronic infection on a worldwide RNA. Note that no change in the levels of the viral transcripts was
basis. Viral vectors containing either the precore pro- detected between wild-type and mutant viral genomes. (B) RNase pro-
tection assay of encapsidated pregenomic RNA. Lane P represents themoter or the stop codon mutation introduced into the
343-nt-long RNA probe containing the DraI–BglII-derived HBV se-precore ORF directed higher levels of HBV DNA synthe-
quence. Lane Y represents 2 mg of yeast RNA as a negative control.sis when compared to wild-type virus following transfec-
Total RNA extracted from cells transfected with a HBeAg-expressing
tion into HCC cell lines. Therefore, two regions have plasmid was used as a positive control as indicated by a plus sign.
been found in the viral genome where mutations will lead The arrows indicate the protected RNA fragments corresponding to the
3* and 5* ends of the pregenomic RNA (200 and 166 nt, respectively).to an enhanced viral replication phenotype. For example,
AID VY 8594 / 6a3b$$$$23 06-06-97 13:42:13 vira AP: Virology
380 SCAGLIONI, MELEGARI, AND WANDS
al., 1996). Such studies are consistent with a recent ob- confer a different phenotype such as that observed with
the fulminant hepatitis B mutant strain described byservation indicating that the promoter elements used in
the synthesis of the precore and pregenomic RNAs are Baumert et al. (1996). In their experiments with a geno-
type A virus, the precore promoter mutations appearedgenetically distinct and separately regulated (Yu and
Mertz, 1996). to produce a high-replication phenotype whereas in our
experiments with a genotype D virus the same mutationsAlthough the amount of pregenomic RNA present in
the cytoplasm was unchanged when comparing the lev- led to only a twofold increase in viral replication. How-
ever, in both viral strains, the trend toward a higher repli-els produced by wild-type and mutant viruses, the con-
centration of pregenomic RNA encapsidated into core cation phenotype was observed with these precore pro-
moter mutations.particles was increased fivefold in the payw*28PM con-
struct that contains the precore stop codon and only The enhanced replication exhibited by the mutant virus
containing the precore stop codon mutation at positiontwofold in the paywOMPM construct that contains the
precore promoter mutations. To rule out the possibility 28 described in the present investigation may have im-
portant biologic consequences in vivo. The increasedthat the TGG to TAG transition that introduced the stop
codon at position 28 in the precore ORF was responsible level of viral replicative forms may lead to accumulation
of viral antigens within infected hepatocytes and promotefor increasing the encapsidation efficiency of the prege-
nomic RNA, the same mutation was introduced into liver injury through an enhanced host immune response
(Chisari and Ferrari, 1995). Increased levels of mutantpCMVHBV, a plasmid that expresses an authentic prege-
nomic RNA but does not synthesize any precore RNA viral replicative forms may lead to accumulation of
cccDNA in the nucleus and result in increased cellularspecies (Fallows and Goff, 1994). Our finding indicating
that this plasmid does not synthesize any detectable cytopathic effects as well (Lenhoff and Summers, 1994).
Finally, in vitro and in vivo studies with well-defined muta-HBeAg following transient transfection in HuH7 and
HepG2 cells suggests that the transfected DNA is the tions in HBV strains of known genotype will be required
to assess the potential pathogenic role of alterations inmajor template for viral transcription in this tissue culture
system and not covalently closed circular HBV DNA precore promoter, precore, and preS gene regions with
respect to their effects on viral replication either alone(cccDNA). Indeed, under these experimental conditions,
there was no increase in HBV replicative forms, indicat- or in combination.
ing that the stop codon mutation did not alter the encapsi-
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